Vitamin E and Alzheimer’s disease: what do we know so far?

References

• Ashraf GM, Chibber S, Zaidi SK, et al. Recent updates on the association between Alzheimer’s disease and vascular dementia. J Med Chem. 2016;12(3):226–237. doi:10.2174/1573406411666151030111820
   Web of Science ®Google Scholar
• Scheltens P, Blennow K, Breteler MBM, et al. Alzheimer’s disease. Lancet. 2016;388(10043):505–517. doi:10.1016/S0140-6736(15)01124-126921134
   PubMed Web of Science ®Google Scholar
• Perl DP. Neuropathology of Alzheimer’s disease. Mt Sinai J Med. 2010;77(1):32–42. doi:10.1002/msj.2015720101720
   PubMedGoogle Scholar
• Prince M, Wimo A, Guerchet M, Ali GC, Wu YT, Prina N Alzheimer’s Disease International. World Alzheimer Report; Alzheimers Disease International: London, UK; 2015.
   Google Scholar
• Wimo A, Jonsson L, Bond J, Prince M, Winblad B. The worldwide economic impact of dementia 2010. Alzheimers Dement. 2013;9(1):1. doi:10.1016/j.jalz.2012.11.00623305821
   PubMed Web of Science ®Google Scholar
• Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement. 2007;3(3):186–191. doi:10.1016/j.jalz.2007.04.38119595937
   PubMed Web of Science ®Google Scholar
• Niemantsverdriet E, Valckx S, Bierke M and Engelborghs S. Alzheimer’s disease and CSF biomarkers: clinical indications and rationale use. Acta Neurol Belg. 2017;117(3):591–602. doi:10.1007/s13760-017-0816-528752420
   PubMed Web of Science ®Google Scholar
• Cui Y, Liu B, Luo S, et al. Alzheimer’s disease neuroimaging initiative. Identification of conversion from mild cognitive impairment to Alzheimer’s disease using multivariate predictors. PLoS One. 2011;6(7):e21896. doi:10.1371/journal.pone.002189621814561
   PubMed Web of Science ®Google Scholar
• Kumar A, Singh A. A review on Alzheimer’s disease pathophysiology and its management: an update. Pharmacol Rep. 2015;67(2):195–203.25712639
   PubMed Web of Science ®Google Scholar
• Ghezzi L, Scarpini E, Galimberti D. Disease-modifying drugs in Alzheimer’s disease. Drug Des Devel Ther. 2013;7:1471.
   PubMed Web of Science ®Google Scholar
• Alzheimer A, Stelzmann RA, Schnitzlein HN, Murtagh FR. An English translation of Alzheimer’s 1907 paper, “Uber eine eigenartige Erkankung der Hirnrinde”. Clin Anat. 1995;8(6):429–431. doi:10.1002/ca.9800806128713166
   PubMedGoogle Scholar
• Cummings JL, Cole G. Alzheimer disease. JAMA. 2002;287(18):2335–2338. doi:10.1001/jama.287.18.233511988038
   PubMed Web of Science ®Google Scholar
• Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down Syndrome. Proc Natl Acad Sci USA. 1985;82(12):4245–4249. doi:10.1073/pnas.82.12.42453159021
   PubMed Web of Science ®Google Scholar
• Castellano JM, Kim J, Stewart FR, et al. Human apoE isoforms differentially regulate brain amyloid- β peptide clearance. Sci Transl Med. 2011;3:89ra57. doi:10.1126/scitranslmed.3002156
   PubMed Web of Science ®Google Scholar
• Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Ann Rev Neurosci. 2001;24(1):1121–1159. doi:10.1146/annurev.neuro.24.1.112111520930
   PubMed Web of Science ®Google Scholar
• Giannakopoulos P, Herrmann FR, Bussière T, et al. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s Disease. Neurology. 2003;60(9):1495–1500. doi:10.1212/01.wnl.0000063311.58879.0112743238
   PubMed Web of Science ®Google Scholar
• Xia W, Mo H. Potential of tocotrienols in the prevention and therapy of Alzheimer’s disease. J Nutr Biochem. 2016;31:1–9. doi:10.1016/j.jnutbio.2015.10.01127133418
   PubMed Web of Science ®Google Scholar
• Yao ZX, Papadopoulos. Function of β-amyloid in cholesterol transport: a lead to neurotoxicity. Faseb J. 2002;16(12):1677–1679. doi:10.1096/fj.02-0285fje12206998
   PubMed Web of Science ®Google Scholar
• Cutler RG, Kelly J, Storie K, et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer’s disease. Proc Natl Acad Sci USA. 2004;101(7):2070–2075. doi:10.1073/pnas.030579910114970312
   PubMed Web of Science ®Google Scholar
• McGuinness B, Craig D, Bullock R, Passmore P. Statins for the prevention of dementia. Cochrane Databse Syst Rev. 2016;(1):CD003160. doi:10.1002/14651858.CD003160.pub3
   Web of Science ®Google Scholar
• Karran E, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov. 2011;10(9):698. doi:10.1038/nrd350521852788
   PubMed Web of Science ®Google Scholar
• Mecocci P, Boccardi V, Cecchetti R, et al. A long journey into aging, brain aging, and Alzheimer’s disease following the oxidative stress tracks. J Alzheimers Dis. 2018;62(3):1319–1335. doi:10.3233/JAD-17073229562533
   PubMed Web of Science ®Google Scholar
• Swerdlow RH, Khan SM. A “mitochondrial cascade hypothesis” for sporadic Alzheimer’s disease. Med Hypotheses. 2004;63(1):8–20. doi:10.1016/j.mehy.2003.12.04515193340
   PubMed Web of Science ®Google Scholar
• Swerdlow RH. Alzheimer’s disease pathologic cascades: who comes first, what drives what. Neurotox Res. 2012;22(3):182–194. doi:10.1007/s12640-011-9272-921913048
   PubMed Web of Science ®Google Scholar
• Swerdlow RH. Brain aging, Alzheimer’s disease, and mitochondria. Biochim Biophys Acta. 2011;1812(12):1630–1639. doi:10.1016/j.bbadis.2011.08.01221920438
   PubMed Web of Science ®Google Scholar
• Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer’s disease. J Neurosci. 2005;25(39):8843–8853. doi:10.1523/JNEUROSCI.2868-05.200516192374
   PubMed Web of Science ®Google Scholar
• Heppner FL. Ransohoff RM and Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci. 2015;16(6):358. doi:10.1038/nrn388025991443
   PubMed Web of Science ®Google Scholar
• Zuo L, Zhou T, Pannell BK, Ziegler AC, Best TM. Biological and physiological role of reactive oxygen species–the good, the bad and the ugly. Acta Physiol. 2015;214(3):329–348. doi:10.1111/apha.2015.214.issue-3
   PubMed Web of Science ®Google Scholar
• Nunomura A, Perry G, Aliey G, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropath Exp Neurol. 2001;60(8):759–767. doi:10.1093/jnen/60.8.75911487050
   PubMed Web of Science ®Google Scholar
• Gustaw-Rothenberg K, Kowalczuk K, Stryjecka-Zimmer M. Lipids’ peroxidation markers in Alzheimer’s disease and vascular dementia. Geriatr Gerontol. 2010;10(2):161–166.
   Web of Science ®Google Scholar
• Mosconi L, Pupi A, De Leon MJ. Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer’s disease. Ann NY Acad Sci. 2008;1147(1):180–195. doi:10.1196/annals.1427.00719076441
   PubMed Web of Science ®Google Scholar
• Boccardi V, Baroni M, Mangialasche F, Mecocci P. Vitamin E family: role in the pathogenesis and treatment of Alzheimer’s disease. Alzheimers Dement. 2016;2(3):182–191.
   Google Scholar
• Curti D, Rognoni F, Gasparini L, et al. Oxidative metabolism in fibroblasts derived from sporadic Alzheimer’s disease (AD) patients. Neurosci Lett. 2008;1147(1):180–195.
   Google Scholar
• Nelson ME, Reieski WJ, Blair SN, et al. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation. 2007;116(9):1094. doi:10.1161/CIRCULATIONAHA.107.18565017671236
   PubMed Web of Science ®Google Scholar
• Jack C. The vascular hypothesis of Alzheimer’s disease: bench to bedside and beyond. Neurodegener Dis. 2010;7(1–3):116–121. doi:10.1159/00028552020173340
   PubMed Web of Science ®Google Scholar
• Feng Y, Wang X. Antioxidant therapies for Alzheimer’s disease. Oxid Med Cell Longev. 2012;2012:472932. doi:10.1155/2012/47293222888398
   PubMed Web of Science ®Google Scholar
• Grundman M. Vitamin E and Alzheimer disease: the basis for additional clinical trials. Am J Clin Nutr. 2000;71(2):630S–636S. doi:10.1093/ajcn/71.2.630s10681271
   PubMed Web of Science ®Google Scholar
• Bieri JG. Sources and consumption of antioxidants in the diet. J Am Oil Chem Soc. 1984;61(12):1917–1918. doi:10.1007/BF2540831
   Web of Science ®Google Scholar
• Grimm M, Mett J, Hartmann T. The impact of vitamin E and other fat-soluble vitamins on Alzheimer’s disease. Int J Mol Sci. 2016;17(11):1785. doi:10.3390/ijms17111785
   Web of Science ®Google Scholar
• Yap SP, Yuen KH, Wong JW. Pharmacokinetics and bioavailability of α−, γ−and δ− tocotrienols under different food status. J Pharm Pharmacol. 2001;53(1):67–71.11206194
   PubMed Web of Science ®Google Scholar
• Joshi YB, Praticò D. Vitamin E in aging, dementia and Alzheimer’s disease. Biofactors. 2012;38(2):90–97. doi:10.1002/biof.19522422715
   PubMed Web of Science ®Google Scholar
• Weinstein SJ, Peters U, Ahn J, et al. Serum a-tocopherol and g-tocopherol concentrations and prostate cancer risk in the PLCO screening trial: a nested case-control study. PLoS One. 2012;7:e40204. doi:10.1371/journal.pone.004020422792240
   PubMed Web of Science ®Google Scholar
• Wang X, Quinn PJ. Vitamin E and its function in membranes. Prog Lipid Res. 1999;38(4):309–336.10793887
   PubMed Web of Science ®Google Scholar
• Müller L, Theile K, Böhm V. In vitro antioxidant activity of tocopherols and tocotrienols and comparison of vitamin E concentration and lipophilic antioxidant capacity in human plasma. Mol Nutr Food Res. 2010;54(5):731–742. doi:10.1002/mnfr.20090039920333724
   PubMed Web of Science ®Google Scholar
• Raederstorff D, Wyss A, Calder PC, Weber P, Eggersdorfer M. Vitamin E function and requirements in relation to PUFA. Br J Nutr. 2015;114(8):1113–1122. doi:10.1017/S000711451500272X26291567
   PubMed Web of Science ®Google Scholar
• Serbinova EA, Packer L. Antioxidant properties of α-tocopherol and α-tocotrienol. Meth Enzym. 1994;234:354–366.7808307
   PubMed Web of Science ®Google Scholar
• Huang D, Ou B, Hampsch-Woodill M, Flanagan JA, Deemer EK. Development and validation of oxygen radical absorbance capacity assay for lipophilic antioxidants using randomly methylated β-cyclodextrin as the solubility enhancer. J Agric Food Chem. 2002;50(7):1815–1821.11902917
   PubMed Web of Science ®Google Scholar
• Brigelius-Flohé R. Vitamin E: the shrew waiting to be tamed. Free Radic Biol Med. 2009;46(5):543–554. doi:10.1016/j.freeradbiomed.2008.12.00719133328
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Niki E, Noguchi N. Comparative study on the action of tocopherols and tocotrienols as antioxidant: chemical and physical effects. Chem Phys Lipids. 2003;123(1):63–75.12637165
   PubMed Web of Science ®Google Scholar
• Jiang Q. Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy. Free Radic Biol Med. 2014;72:76–90. doi:10.1016/j.freeradbiomed.2014.03.03524704972
   PubMed Web of Science ®Google Scholar
• Saito Y, Nishio K, Akazawa YO, et al. Cytoprotective effects of Vitamin E homologues against glutamate-induced cell death in immature primary cortical neuron cultures: tocopherols and tocotrienols exert similar effects by antioxidant function. Free Radic Biol Med. 2010;49:1542–1549. doi:10.1016/j.freeradbiomed.2010.08.01620736061
   PubMed Web of Science ®Google Scholar
• Lee CY, Wan F. Vitamin E supplementation improves cell-mediated immunity and oxidative stress of Asian men and women. J Nutr. 2000;130(12):2932–2937. doi:10.1093/jn/130.12.293211110849
   PubMed Web of Science ®Google Scholar
• De la Fuente M, Hernanz A, Guayerbas N. Manuel Victor V, Amalich F. Vitamin E ingestion improves several immune functions in elderly men and women. Free Radic Res. 2008;42(3):272–280. doi:10.1080/1071576080189883818344122
   PubMed Web of Science ®Google Scholar
• Rota C, Rimbach G, Minihane AM, Stoecklin E, Barella L. Dietary vitamin E modulates differential gene expression in the rat hippocampus: potential implications for its neuroprotective properties. Nutr Neurosci. 2005;8(1):21–29. doi:10.1080/1028415040002712315909764
   PubMed Web of Science ®Google Scholar
• Giraldo E, Lloret A, Fuchsberger T, Viña J. Aβ and tau toxicities in Alzheimer’s are linked via oxidative stress-induced p38 activation: protective role of vitamin E. Redox Biol. 2014;2:873–877. doi:10.1016/j.redox.2014.03.00225061569
   PubMed Web of Science ®Google Scholar
• Jiang Q, Yin X, Lill MA, Danielson ML, Freiser H, Huang J. Long-chain carboxychromanols, metabolites of vitamin E, are potent inhibitors of cyclooxygenases. Proc Natl Acad Sci USA. 2008;105(51):20464–20469. doi:10.1073/pnas.081096210619074288
   PubMed Web of Science ®Google Scholar
• Copp RP, Wisniewski T, Hentati F, et al. Localization of alpha-tocopherol transfer protein in the brains of patients with ataxia with vitamin E deficiency and other oxidative stress related neurodegenerative disorders. Brain Res. 1999;822(1–2):80–87. doi:10.1016/s0006-8993(99)01090-210082886
   PubMed Web of Science ®Google Scholar
• Elkamil A, Johansen KK, Aasly J. Ataxia with vitamin E deficiency in Norway. Mov Disord. 2015;8(1):33. doi:10.14802/jmd.14030
   Google Scholar
• Wang H, O’Reilly EJ, Weisskopf MG, et al. Vitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from 5 prospective cohort studies. Am J Epidemiol. 2011;173(6):595–602. doi:10.1093/aje/kwq41621335424
   PubMed Web of Science ®Google Scholar
• Etminan M, Gill SS, Samii A. Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson’s disease: a meta-analysis. Lancet Neurol. 2005;4(6):362–365. doi:10.1016/S1474-4422(05)70097-115907740
   PubMed Web of Science ®Google Scholar
• Chin KY, Tay S. A review on the relationship between tocotrienol and Alzheimer Disease. Nutrients. 2018;10:(7)881. doi:10.3390/nu10070881
   Web of Science ®Google Scholar
• Krycer JR, Phan L, Brown AJ. A key regulator of cholesterol homoeostasis, SREBP-2, can be targeted in prostate cancer cells with natural products. Biochem J. 2012;446(2):191–201. doi:10.1042/BJ2012054522657538
   PubMed Web of Science ®Google Scholar
• Mo H, Yeganehjoo H, Shah A, Mo WK, Soelaiman IN, Shen CL. Mevalonate-suppressive dietary isoprenoids for bone health. J Nutr Biochem. 2012;23(12):1543–1551. doi:10.1016/j.jnutbio.2012.07.00722981371
   PubMed Web of Science ®Google Scholar
• Song B-L, DeBose-Boyd RA. Insig-dependent ubiquitination and degradation of 3-hydroxy-3-methylglutaryl coenzyme a reductase stimulated by delta- and gamma-tocotrienols. J Biol Chem. 2006;281(35):25054–25061. doi:10.1074/jbc.M60557520016831864
   PubMed Web of Science ®Google Scholar
• Khor HT, Ng TT. Effects of administration of alpha-tocopherol and tocotrienols on serum lipids and liver HMGCoA reductase activity. Int J Food Sci Nutr. 2000;51Suppl:S3–S11. doi:10.1080/096374800750049521
   Google Scholar
• Zaman Z, Roche S, Fielden P, et al. Plasma concentrations of vitamins and E and carotenoids in Alzheimer’s disease. Age Ageing. 1992;104(6–7):703–710.
   Google Scholar
• Jiménez-Jiménez FJ, de Bustos F, Molina JA, et al. Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer’s disease. J Neural Transm. 1997;21(2):91–94.
   Google Scholar
• Sinclair AJ, Bayer AJ, Johnston J, Warner C, Maxwell SR. Alterd plasma antioxidant status in subjects with Alzheimer’s disease and vascular dementia. Int J Geriatr Psychiatry. 1998;13(12):840–845.9884908
   PubMed Web of Science ®Google Scholar
• Foy CJ, Passmore AP, Vahidassr MD, Young IS, Lawson JT. Plasma chain-breaking antioxidants in Alzheimer’s disease, vascular dementia and Parkinson’s disease. Q J Med. 1999;92(1):39–45. doi:10.1093/qjmed/92.1.39
   Google Scholar
• Bourdel-Marchasson I, Delmas-Beauvieux MC, Peuchant E, et al. Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing. 2001;30(3):235–241. doi:10.1093/ageing/30.3.23511443025
   PubMed Web of Science ®Google Scholar
• Polidori MC, Mecocci P. Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease. J Alzheimers Dis. 2002;4(6):517–522.12629261
   PubMed Web of Science ®Google Scholar
• Mecocci P, Polidori M, Cherubini A, et al. Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch Neurol. 2002;59(5):794–798.12020262
   PubMed Web of Science ®Google Scholar
• Rinaldi P, Poliori MC, Metastasio A, et al. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease. Neurobiol Aging. 2003;24(7):915–919.12928050
   PubMed Web of Science ®Google Scholar
• Baldeiras I, Santana I, Proenca MT, et al. Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer’s disease. J Alzheimers Dis. 2008;15:117–128.18780972
   PubMed Web of Science ®Google Scholar
• Mangialasche F, Xu W, Kivipelto M, et al. Tocopherols and tocotrienols plasma levels are associated with cognitive impairment. Nerurobiol Aging. 2012;33(10):2282–2290. doi:10.1016/j.neurobiolaging.2011.11.019
   PubMed Web of Science ®Google Scholar
• Giavarotti L, Simon KA, Azzalis LA, et al. Mild systemic oxidative stress in the subclinical stage of Alzheimer’s disease. Oxid Med Cell Longev. 2013;2013:609019. doi:10.1155/2013/60901924454987
   PubMed Web of Science ®Google Scholar
• Mullan K, Williams MA, Cardwell CR, et al. Serum concentrations of vitamin E and carotenoids are altered in Alzheimer’s disease: a case-control study. Alzheimers Dement Trans Clin Interv. 2017;3:432–439.
   PubMedGoogle Scholar
• Schippling S, Kontush A, Arlt S, et al. Increased lipoprotein oxidation in Alzheimer’s disease. Free Radic Biol Med. 2000;28(3):351–360.10699746
   PubMed Web of Science ®Google Scholar
• Ryglewicz D, Rodo M, Kunicki PK, et al. Plasma antioxidant activity and vascular dementia. J Neurol Sci. 2002;203:195–197.12417383
   PubMed Web of Science ®Google Scholar
• Charlton KE, Rabinowitz TL, Geffen LN, Dhansay MA. Lowered plasma vitamin C but not vitamin E concentration in dementia patients. J Nutr Health Aging. 2004;8(2):99–108.14978605
   PubMedGoogle Scholar
• Mas E, Dupuy AM, Artero S, et al. Functional vitamin E deficiency in ApoE4 patients with Alzheimer’s disease. Dement Geriatr Cogn Disord. 2006;21(3):198–204. doi:10.1159/00009086816407653
   PubMed Web of Science ®Google Scholar
• Von Arnim CA, Herbolsheimer F, Nikolaus T, et al. Dietary antioxidants and dementia in a population-based case-control study among older people in South Germany. J Alzheimers Dis. 2012;31(4):717–724. doi:10.3233/JAD-2012-12063422710913
   PubMed Web of Science ®Google Scholar
• Jeandel C, Nicolas MB, Dubois F, Nabet-Belleville F. Penin F and Cuny G. Lipid peroxidation and free radical scavengers in Alzheimer’s disease. Gerontology. 1989;35(5–6):275–282. doi:10.1159/0002130372630382
   PubMed Web of Science ®Google Scholar
• Lopes Da Silva S, Vellas B, Elemans S, et al. Plasma nutrient status of patients with Alzheimer’s disease: systematic review and meta-analysis. Alzheimers Dement. 2014;10(4):485–502. doi:10.1016/j.jalz.2013.05.177124144963
   PubMed Web of Science ®Google Scholar
• Mullan K, Cardwell CR, McGuinness B, Woodside JV, McKay GJ. Plasma antioxidant status in patients with Alzheimer’s disease and cognitively intact elderly: a meta-analysis of case-control studies. J Alzheimers Dis. 2018;62(1):305–317. doi:10.3233/JAD-17075829439339
   PubMed Web of Science ®Google Scholar
• Dong Y, Chen X, Liu Y, et al. Do low-serum vitamin E levels increase the risk of Alzheimer disease in older people? Evidence from a meta-analysis of case-control studies. Int J Geriatr Psychiatry. 2018;33(2):e257–e263. doi:10.1002/gps.478028833475
   PubMed Web of Science ®Google Scholar
• De Wilde MC, Vellas B, Girault E, Yavuz AC, Sijben JW. Lower brain and blood nutrient status in Alzheimer’s disease: results from meta-analyses. Alzheimers Dement. 2017;3(3):416–431.
   Google Scholar
• Liu G, Zhao Y, Jin S, et al. Circulating vitamin E levels and Alzheimer’s disease: a Mendelian randomization study. Neurobiol Aging. 2018;72:189–e1.
   Web of Science ®Google Scholar
• Mangialasche F, Kivipelto M, Mecocci P, et al. High plasma levels of vitamin E forms and reduced Alzheimer’s disease risk in advanced age. J Alzheimers Dis. 2010;20(4):1029–1037.20413888
   PubMed Web of Science ®Google Scholar
• Mangialasche F, Westman E, Kivipelto M, et al. Classification and prediction of clinical diagnosis of Alzheimer’s disease based on MRI and plasma measures of α‐/γ‐tocotrienols and γ‐tocopherol. J Intern Med. 2013;273(6):602–621.23343471
   PubMed Web of Science ®Google Scholar
• Mangialasche F, Solomon A, Kàrehold I, et al. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults. Exp Gerontol. 2013;48(12):1428–1435.24113154
   PubMed Web of Science ®Google Scholar
• Morris MC, Beckett LA, Scherr PA, et al. Vitamin E and vitamin E supplement use and the risk of incident Alzheimer disease. Alzheimer Dis Assoc Disord. 1998;12:121–126.9772012
   PubMed Web of Science ®Google Scholar
• Zandi PP, Anthony JC, Khachaturian AS, et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol. 2004;61(1):82–88.14732624
   PubMed Web of Science ®Google Scholar
• Basambombo LL, Carmichael PH, Côté S, Laurin D. Use of vitamin E and C supplements for the prevention of cognitive decline. Ann Pharmacother. 2017;51(2):118–124.27708183
   PubMed Web of Science ®Google Scholar
• Morris MC, Evans DA, Bienias JL, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA. 2002;287(24):3230–3237.12076219
   PubMed Web of Science ®Google Scholar
• Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA. 2002;287(24):3223–3229.12076218
   PubMed Web of Science ®Google Scholar
• Morris MC, Evans DA, Tangney CC, et al. Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am J Clin Nutr. 2005;81(2):508–514.15699242
   PubMed Web of Science ®Google Scholar
• Devore EE, Grodstein F, van Rooij FJ, et al. Dietary antioxidants and long-term risk of dementia. Arch Neurol. 2010;67(7):819–825.20625087
   PubMedGoogle Scholar
• Masaki KH, Losonczy KG, Ismirlian G, et al. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology. 2000;54(6):1265–1272.10746596
   PubMed Web of Science ®Google Scholar
• Luchsinger JA, Tang MX, Shea S, Maveux R. Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol. 2003;60(2):203–208.12580704
   PubMedGoogle Scholar
• Gray SL, Anderson ML, Crane PK, et al. Antioxidant vitamin supplement use and risk of dementia or Alzheimer’s disease in older adults. J Am Geriatr Soc. 2008;56(2):291–295. doi:10.1111/j.1532-5415.2007.01531.x18047492
   PubMed Web of Science ®Google Scholar
• Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. New Engl J Med. 1997;336(17):1216–1222. doi:10.1056/NEJM1997042433617049110909
   PubMed Web of Science ®Google Scholar
• Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. New Engl J Med. 2005;352(23):2379–2388. doi:10.1056/NEJMoa05015115829527
   PubMed Web of Science ®Google Scholar
• Lloret A, Badía MC, Mora NJ, Pallardó FV, Alonso MD, Viña J. Vitamin E paradox in Alzheimer’s disease: it does not prevent loss of cognition and may even be detrimental. J Alzheimers Dis. 2009;17(1):143–149. doi:10.3233/JAD-2009-103319494439
   PubMed Web of Science ®Google Scholar
• Dysken MW, Sano M, Asthana S, et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA. 2014;311(1):33–44. doi:10.1001/jama.2013.28283424381967
   PubMed Web of Science ®Google Scholar
• Kryscio RJ, Abner EL, Caban-Holt A, et al. Association of antioxidant supplement use and dementia in the prevention of Alzheimer’s disease by vitamin E and selenium trial (PREADViSE). JAMA Neurol. 2017;74(5):567–573. doi:10.1001/jamaneurol.2016.577828319243
   PubMed Web of Science ®Google Scholar
• Miller ER III, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142(1):37–46. doi:10.7326/0003-4819-142-1-200501040-0011015537682
   PubMed Web of Science ®Google Scholar
• Naeini AA, Elmadfa I, Djazayery A, et al. The effect of antioxidant vitamins E and C on cognitive performance of the elderly with mild cognitive impairment in Isfahan, Iran: a double-blind, randomized, placebo-controlled trial. Eur J Nutr. 2014;53(5):1255–1262. doi:10.1007/s00394-013-0628-124326981
   PubMed Web of Science ®Google Scholar
• Galasko DR, Peskind E, Clark CM, et al. For Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Arch Neurol. 2012;69(7):836–841. doi:10.1001/archneurol.2012.8522431837
   PubMedGoogle Scholar
• Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956;11(3):298–300.13332224
   PubMedGoogle Scholar
• Ghezzi P, Jaquet V, Marcucci F, Schmidt HH. The oxidative stress theory of disease: levels of evidence and epistemological aspects. Br J Pharmacol. 2017;174(12):1784–1796. doi:10.1111/bph.1354427425643
   PubMed Web of Science ®Google Scholar
• Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. 2012:(3):CD007176. doi:10.1002/14651858.CD007176.pub2
   Web of Science ®Google Scholar
• Winterbourn CC. The challenges of using fluorescent probes to detect and quantify specific reactive oxygen species in living cells. Biochim Biophys Acta. 2014;1840(2):730–738. doi:10.1016/j.bbagen.2013.05.00423665586
   PubMed Web of Science ®Google Scholar
• Zielonka J, Hardy M, Michalski R, et al. Recent developments in the probes and assays for measurement of the activity of NADPH oxidases. Cell Biochem Biophys. 2017;75(3–4):335–349. doi:10.1007/s12013-017-0813-628660426
   PubMed Web of Science ®Google Scholar
• Frijhoff J, Winyard PG, Zarkovic N, Davies SS, Stocker R, Cheng D. Clinical relevance of biomarkers of oxidative stress. Antioxid Redox Signal. 2015;23(14):1144–1170. doi:10.1089/ars.2015.631726415143
   PubMed Web of Science ®Google Scholar
• Mariani E, Mangialasche F, Feliziani FT, et al. Effects of zinc supplementation on antioxidant enzyme activities in healthy old subjects. Exp Gerontol. 2008;43(5):445–451. doi:10.1016/j.exger.2007.10.01218078731
   PubMed Web of Science ®Google Scholar
• Farina N, Llewellyn D, Isaac MG, Tabet N. Vitamin E for Alzheimer’s dementia and mild cognitive impairment.
   Google Scholar
• Corbett A, Ballard C. The value of vitamin E as a treatment for Alzheimer’s disease remains unproven despite functional improvement, due to a lack of established effect on cognition or other outcomes from RCTs. Evid Based Med. 2014;19(4):140. doi:10.1136/eb-2014-10174124639394
   PubMedGoogle Scholar
• Ancelin ML, Christen Y, Ritchie K. Is antioxidant therapy a viable alternative for mild cognitive impairment? Examination of the evidence. Dement Geratr Cogn Dis. 2007;24(1):1–9. doi:10.1159/000102567
   Web of Science ®Google Scholar
• Niki E. Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence. Free Radic Biol Med. 2014;66:3–12. doi:10.1016/j.freeradbiomed.2013.03.02223557727
   PubMed Web of Science ®Google Scholar
• Constantinescu A, Han D, Packer L. Vitamin E recycling in human erythrocyte membranes. J Biol Chem. 1993;268(15):10906–10913.8388377
   PubMed Web of Science ®Google Scholar
• Bowry VW, Ingold KU, Stocker R. Vitamin E in human low-density lipoprotein: when and how this antioxidant becomes a pro- oxidant. Biochem J. 1992;288(2):341–344. doi:10.1042/bj28803411463440
   PubMed Web of Science ®Google Scholar
• Rietjens IM, Boersma MG, de Haan L, et al. The pro-oxidant chemistry of the natural antioxidants vitamin C, vitamin E, carotenoids and flavonoids. Environ Toxicol Pharmacol. 2002;11(3–4):321–333.21782615
   PubMed Web of Science ®Google Scholar
• Pearson P, Lewis SA, Britton J, Young IS, Fogarty A. The pro-oxidant activity of high-dose vitamin E supplements in vivo. BioDrugs. 2006;20(5):271–273. doi:10.2165/00063030-200620050-0000217025373
   PubMed Web of Science ®Google Scholar
• Mecocci P, Polidori MC. Antioxidant clinical trials in mild cognitive impairment and Alzheimer’s disease. Biochim Biophys Acta - Mol Basis Dis. 2012;1822(5):631–638. doi:10.1016/j.bbadis.2011.10.006
   PubMed Web of Science ®Google Scholar
• Bjørneboe A, Bjørneboe GE, Drevon CA. Absorption, transport and distribution of vitamin E. J Nutr. 1990;120(3):233–242. doi:10.1093/jn/120.3.2332181082
   PubMed Web of Science ®Google Scholar
• Richelle M, Enslen M, Hager C, et al. Both free and esterified plant sterols reduce cholesterol absorption and the bioavailability of β-carotene and α-tocopherol in normocholesterolemic humans. Am J Clin Nutr. 2004;80(1):171–177. doi:10.1093/ajcn/80.1.17115213045
   PubMed Web of Science ®Google Scholar
• Goti D, Hammer A, Galla HJ, Malle E, Sattler W. Uptake of lipoprotein‐associated α‐tocopherol by primary porcine brain capillary endothelial cells. J Neurochem. 2000;74(4):1374–1383. doi:10.1046/j.1471-4159.2000.0741374.x10737592
   PubMed Web of Science ®Google Scholar
• Leonard SW, Paterson E, Atkinson JK, Ramakrishnan R, Cross CE, Traber MG. Studies in humans using deuterium-labeled α-and γ-tocopherols demonstrate faster plasma γ-tocopherol disappearance and greater γ-metabolite production. Free Radic Biol Med. 2005;38(7):857–866. doi:10.1016/j.freeradbiomed.2004.12.00115749381
   PubMed Web of Science ®Google Scholar
• Campbell D, Bunker VW, Thomas AJ, Clayton BE. Selenium and vitamin E status of healthy and institutionalized elderly subjects: analysis of plasma, erythrocytes and platelets. Br J Nutr. 1989;62(1):221–227.2789985
   PubMed Web of Science ®Google Scholar
• Shah AA, Khand F, Khand TU. Effect of smoking on serum xanthine oxidase, malondialdehyde, ascorbic acid and α-tocopherol levels in healthy male subjects. Pak J Med Sci. 2015;31(1):146.25878632
   PubMed Web of Science ®Google Scholar
• Gunanti IR, Marks GC, Al-Mamun A, Long KZ. Low serum concentrations of carotenoids and vitamin E are associated with high adiposity in Mexican-American children. J Nutr. 2014;144(4):489–495. doi:10.3945/jn.113.18313724500938
   PubMed Web of Science ®Google Scholar
• Borel P, Desmarchelier C, Nowicki M, Bott R, Tourniaire F. Can genetic variability in α-tocopherol bioavailability explain the heterogeneous response to α-tocopherol supplements? Antioxid Redox Signal. 2015;22:669–678. doi:10.1089/ars.2014.614425289663
   PubMed Web of Science ®Google Scholar
• Major JM, Yu K, Wheeler W, et al. Genome-wide association study identifies common variants associated with circulating vitamin E levels. Hum Mol Genet. 2011;20(19):3876–3883. doi:10.1093/hmg/ddr29621729881
   PubMed Web of Science ®Google Scholar
• Galmés S, Serra F, Palou A. Vitamin E metabolic effects and genetic variants: a challenge for precision nutrition in obesity and associated disturbances. Nutrients. 2018;10(12):1919. doi:10.3390/nu10121919
   PubMed Web of Science ®Google Scholar
• Galli F, Azzi A, Birringer M, et al. Vitamin E: emerging aspects and new directions. Free Radic Biol Med. 2017;102:16–36. doi:10.1016/j.freeradbiomed.2016.09.01727816611
   PubMed Web of Science ®Google Scholar
• Steiner M. Vitamin E, a modifier of platelet function: rationale and use in cardiovascular and cerebrovascular disease. Nutr Rev. 1999;57(10):306–309. doi:10.1111/j.1753-4887.1999.tb06903.x10575906
   PubMed Web of Science ®Google Scholar
• Schürks M, Glynn RJ, Rist PM, Tzourio C, Kurth T. Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ. 2010;341:c5702. doi:10.1136/bmj.c570221051774
   PubMed Web of Science ®Google Scholar
• Klein EA, Thompson IM, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011;306:1549–1556. doi:10.1001/jama.2011.143721990298
   PubMed Web of Science ®Google Scholar
• Gerss J, Kopcke W. The questionable association of vitamin E supplementation and mortality – inconsistent results of different meta-analytic approaches. Cell Mol Biol. 2009;55:OL1111–Q1120.19267994
   PubMed Web of Science ®Google Scholar
• Jiang S, Pan Z, Li H, Li F, Song Y, Qiu Y. Meta-analysis: low-dose intake of vitamin E combined with other vitamins or minerals may decrease all-cause mortality. J Nutr Sci Vitaminol. 2014;60:194–205.25078376
   PubMed Web of Science ®Google Scholar